中宝新材(02439) - 2025 - 年度业绩

Supplemental Announcement to the 2024 Annual Report This announcement provides supplementary details to the 2024 Annual Report, focusing on the share option scheme and board composition Supplemental Details of Share Option Scheme This section details the specific terms, conditions, and procedures of the company's share option scheme, including offer, exercise, and validity Consideration Payable and Offer Period for Share Options - Eligible persons may accept the offer of granted share options within 28 days from the offer date[2] - The consideration for share options is a non-refundable remittance of HK$1.0[2] - Offers not accepted by the acceptance date will be deemed irrevocably rejected[2] Share Option Exercise Conditions and Procedures - Share options must be exercised by the grantee via written notice to the company within the option period, specifying the number of shares to be exercised[3] - Each exercise notice must be accompanied by the full remittance of the total subscription price for the shares involved[3] - The exercise of share options may be subject to a vesting schedule determined at the sole discretion of the Board[4] - In case of grantee's death or permanent disability, their legal representative may exercise unexercised options within 12 months of death/disability[4] - Upon termination of employment (except in specific cases), unexercised options will lapse unless otherwise decided by the Board[4] - In the event of a general offer or scheme of arrangement, grantees are entitled to exercise unexercised options within a specified period[4] - During corporate restructuring or merger, grantees may exercise all or part of their options within a specific period[6] - In case of voluntary liquidation, grantees may exercise options up to two business days before the shareholders' meeting[6] Term of Share Option Scheme - The share option scheme is valid for 10 years from March 31, 2023[5] - The scheme will expire on March 30, 2033, with no further options granted or offered thereafter[5] - All options granted before expiry and unexercised at that time remain valid and exercisable under the scheme's terms[5] Other Supplemental Information This section confirms the supplementary nature of this announcement to the 2024 Annual Report and lists the Board of Directors as of the announcement date - The additional information above supplements the 2024 Annual Report and should be read in conjunction with it, without affecting other information contained therein[7] - The Board of Directors includes Executive Directors Ms. Zhang Yuqiu (Chairperson), Mr. Shan Yuzhu, Mr. Li Xiquan, Mr. Li Peng; and Independent Non-executive Directors Dr. Lai King Ran, Dr. Song Xiaofeng, Mr. Leung Tsz Wing[8]